Chemical Probes logo
GNE-617 | GNE-617 : Inhibitor of NAMPT
RATINGS:
Cellular Use: (1 reviews)

In Model Organisms: (1 reviews)
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
NAMPT
  • IC50:5 nM
  • IC50:2 nM
  • IC50:1.8-7.4 nM
  • EC50:1.1 nM
  • EC50:1.3 nM
Inhibitor
up to 1 uM

Selectivity

In Vitro Selectivity Assessment
Potency Assay Off-Target:
Assessed for CYP inhibition, GNE-617 shows an IC50 of 200 nM against CYP2C9 (warfarin metabolism ass ...

Potency
Cellular
In Vitro

NAMPT

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1021/jm4008664

In Vivo Validations

Mouse
Dose: 5 mg/Kg
Route of delivery: Intravenous
Systemic clearance: 52.4 mL/min/kg
Volume of Distribution at Steady-State: 6.7 L/kg

DOI Reference: 10.1021/jm4008664

Dose: 10 mg/Kg
Route of delivery: Oral
Cmax: 1.21 uM
Tmax: 0.25 h
Area Under the Curve:: 3.06 μM*h
Bioavailability: 41.1%

DOI Reference: 10.1021/jm4008664

Chemical Information

Molecular Formula C21H15F2N3O3S
SMILEs O=C(NCc1ccc(S(=O)(=O)c2cc(F)cc(F)c2)cc1)c1ccc2nccn2c1
InChI InChI=1S/C21H15F2N3O3S/c22-16-9-17(23)11-19(10-16)30(28,29)18-4-1-14(2-5-18)12-25-21(27)15-3-6-20-24-7-8-26(20)13-15/h1-11,13H,12H2,(H,25,27)
Molecular weight 427.08 Da
AlogP 3.375300000000002
HBond acceptors 6
HBond donors 1
Atoms 45

References

Publications

Cross References

canSARChEMBLBindingDBPDB

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews

by SERP
(on 24 Oct 2023)
Cellular Use Rating
In Model Organisms
Single digit nM activity in a range of cell lines. Mouse PK studies indicate good coverage at doses used. Efficacious in U251 human glioblastoma tumor mouse xenograft model at 25 mg/kg PO QDX7. CYP2C9...
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria